(Q34571693)

3 August 2017

1 reference

title

Management of erythema nodosum leprosum by thalidomide: thalidomide analogues inhibit M. leprae-induced TNFalpha production in vitro (English)

1 reference

Erythema nodosum leprosum

3 August 2017

0 references

1 reference

1 reference

Sampaio EP

1

1 reference

3 August 2017

Hernandez MO

series ordinal

2

1 reference

3 August 2017

Carvalho DS

series ordinal

3

1 reference

3 August 2017

Sarno EN

series ordinal

4

1 reference

3 August 2017

1 February 2002

1 reference

Biomedicine and Pharmacotherapy

3 August 2017

1 reference

3 August 2017

56

1 reference

3 August 2017

13-19

1 reference

3 August 2017

1

1 reference

Rediscovering thalidomide: a review of its mechanism of action, side effects, and potential uses

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900147-0

7 January 2021

Potential novel uses of thalidomide: focus on palliative care

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900147-0

7 January 2021

The saga of thalidomide. Neuropathy to embryopathy, with case reports of congenital anomalies

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900147-0

7 January 2021

THALIDOMIDE IN THE TREATMENT OF LEPRA REACTIONS

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900147-0

7 January 2021

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900147-0

7 January 2021

Stereospecific determination, chiral inversion in vitro and pharmacokinetics in humans of the enantiomers of thalidomide.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900147-0

7 January 2021

Binding of thalidomide to alpha1-acid glycoprotein may be involved in its inhibition of tumor necrosis factor alpha production

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900147-0

7 January 2021

Thalidomide on the comeback trail

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900147-0

7 January 2021

Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900147-0

7 January 2021

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900147-0

7 January 2021

Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900147-0

7 January 2021

The Influence of Thalidomide on the Clinical and Immunologic Manifestation of Erythema Nodosum Leprosum

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900147-0

7 January 2021

Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-alpha) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL)

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900147-0

7 January 2021

Cytokine mRNA Expression in Leprosy: a Possible Role for Interferon-gamma and Interleukin-12 in Reactions (RR and ENL)

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900147-0

7 January 2021

Anti-Inflammatory Drugs Block Cytokine mRNA Accumulation in the Skin and Improve the Clinical Condition of Reactional Leprosy Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900147-0

7 January 2021

Inducer-specific bidirectional regulation by thalidomide and phenylphthalimides of tumor necrosis factor-alpha production

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900147-0

7 January 2021

Neutrophils isolated from leprosy patients release TNF-alpha and exhibit accelerated apoptosis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900147-0

7 January 2021

Thalidomide and derivatives: immunological investigations of tumour necrosis factor-alpha (TNF-alpha) inhibition suggest drugs capable of selective gene regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900147-0

7 January 2021

Thalidomide in patients with cachexia due to terminal cancer: preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900147-0

7 January 2021

Synthesis and structure-activity relationships of novel compounds for the inhibition of TNF-alpha production

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900147-0

7 January 2021

Enantioselective inhibition of TNF-alpha release by thalidomide and thalidomide-analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900147-0

7 January 2021

Potent inhibition of tumor necrosis factor-alpha production by tetrafluorothalidomide and tetrafluorophthalimides

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900147-0

7 January 2021

Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900147-0

7 January 2021

Lepromatous leprosy patients show T helper 1-like cytokine profile with differential expression of interleukin-10 during type 1 and 2 reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900147-0

7 January 2021

Inhibition of apoptosis by ionomycin and zinc in peripheral blood mononuclear cells (PBMC) of leprosy patients

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900147-0

7 January 2021

Immunomodulatory assays to study structure-activity relationships of thalidomide

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900147-0

7 January 2021

Inhibition of NF-kappa B activity by thalidomide through suppression of IkappaB kinase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900147-0

7 January 2021

10.1016/S0753-3322(01)00147-0

Identifiers

DOI

1 reference

3 August 2017

1 reference